{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:54:18Z","timestamp":1785876858220,"version":"3.56.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The management of visual field damage in patients with macroprolactinomas is a major therapeutic challenge. We aimed to study the visual morbidity associated with macroprolactinoma and its outcomes following medical and surgical treatment. We aimed to identify predictors of visual recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed patient's data including clinical presentation, serial pituitary magnetic resonance imaging, laboratory tests, visual symptoms and neuro\u2010ophthalmologic examination, visual field tests and optical coherence tomography tests. The main outcome was complete visual field recovery. Descriptive analyses were conducted. Predictors of visual recovery were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>The study cohort included 150 patients with macroprolactinoma [median follow\u2010up, 6.0 years (interquartile range (IQR) 2.9\u201310.6)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At diagnosis, visual field defects were evident in 40 patients (26.7%). At the end of follow\u2010up, 24 out of 39 available visual field tests (61.5%) exhibited complete recovery. Patients that achieved complete visual recovery had smaller macroadenomas at diagnosis [30.5\u2009mm (15.0\u201380.0) vs. 42.0\u2009mm (30.0\u201385.0),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.01], lower baseline serum prolactin levels [1414\u2009mcg\/L (489\u20133586) vs. 4119\u2009mcg\/L (2715\u20136315),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.01], lower rates of central hypogonadism (78.3% vs. 93.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.05) and central hypothyroidism (20.8% vs. 53.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.04), lower rates of compressive optic neuropathy (35.3% vs. 87.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.02) and a better visual acuity (better than 6\/8 in both eyes, 93.7% vs. 28.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our cohort of 150 patients with macroprolactinoma, 40 patients (26.7%) presented with visual field defects, of which 61.5% achieved complete visual recovery with treatment. Patients that achieved complete visual recovery presented with smaller macroadenomas, lower serum prolactin levels, lower rates of central hypogonadism and central hypothyroidism, lower rates of compressive optic neuropathy and better visual acuity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.15120","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T02:54:17Z","timestamp":1724036057000},"page":"648-658","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Visual morbidity in macroprolactinoma: A retrospective cohort study"],"prefix":"10.1111","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital Rabin Medical Center Petah Tikva Israel"},{"name":"Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-1360","authenticated-orcid":false,"given":"Hadar","family":"Duskin\u2010Bitan","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital Rabin Medical Center Petah Tikva Israel"},{"name":"Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8025","authenticated-orcid":false,"given":"Hiba","family":"Masri\u2010Iraqi","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital Rabin Medical Center Petah Tikva Israel"},{"name":"Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital Rabin Medical Center Petah Tikva Israel"},{"name":"Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital Rabin Medical Center Petah Tikva Israel"},{"name":"Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02557.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0349"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030979"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14541"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0392"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-005-5111-4"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0791-7"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0013"},{"issue":"8","key":"e_1_2_7_11_1","article-title":"Gender disparities in prolactinomas: unravelling clinical patterns, metabolic variations, and treatment responses","volume":"15","author":"Baba MS","year":"2023","journal-title":"Cureus"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-01009-y"},{"issue":"1","key":"e_1_2_7_13_1","first-page":"32","article-title":"Improving quality of life in patients with pituitary tumours","volume":"9","author":"Crespo I","year":"2013","journal-title":"Eur Endocrinol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0860-4"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-13-2-220"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01039.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03364.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.3171\/2014.10.JNS141204"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-01757-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(85)33853-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00886-5"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad393"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-020-01408-x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-009-0492-1"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020152"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1127"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/1793-5482.149995"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0651"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1249"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0794"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.02.027"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad758"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0261-4"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1786740"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002186"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.15120","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.15120","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.15120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:50:59Z","timestamp":1771221059000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.15120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,18]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/cen.15120"],"URL":"https:\/\/doi.org\/10.1111\/cen.15120","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,18]]},"assertion":[{"value":"2024-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}